Da Vinci robotic surgical console with intraoperative ultrasound of pancreatic head

NON-THERMAL NANOKNIFE & CONVERSION THERAPY

Advanced Pancreatic Cancer Care in China

Pancreatic cancer is notoriously challenging because tumors frequently wrap around major abdominal blood vessels. China’s top pancreatic cancer centers are global leaders in irreversible electroporation (NanoKnife ablation), complex vascular reconstruction surgery, and multi-agent conversion therapies designed to turn inoperable tumors into candidates for successful surgical removal.

  • Pancreatic Adenocarcinoma & Neuroendocrine Tumors (pNET)
  • Locally Advanced Tumors Enveloping Celiac or Mesenteric Arteries
  • Patients Seeking Safe Ablation Without Thermal Vessel Damage
  • World-Leading Experience in NanoKnife (IRE) Electroporation
  • Specialized Arterial & Venous Vascular Reconstruction Surgery
  • Multidisciplinary Board of Pancreatic Surgeons & Interventionalists

ADVANCED TREATMENT OPTIONS

Key Pancreatic Cancer Treatments

Non-thermal NanoKnife (IRE) ablation, vascular reconstruction surgery, and multi-agent conversion therapy.

Non-Thermal NanoKnife (IRE)

Uses microsecond high-voltage electrical pulses to open pores in cancer cells and destroy them, leaving blood vessels, bile ducts, and nerves completely intact.
Learn More

Vascular Reconstruction Surgery

Specialized surgical teams capable of resecting tumors intertwined with major abdominal vessels and reconstructing the blood supply safely.
Learn More

Intensive Conversion Regimens

Advanced multi-agent systemic chemotherapy paired with novel targeted drugs to shrink stubborn tumors into surgically resectable stages.
Learn More

WHY CHOOSE US

Why Choose China for Pancreatic Cancer

A specialized clinical pathway connecting international patients with China's highest-volume pancreatic surgery institutes.

China has accumulated extensive clinical volume in treating locally advanced pancreatic cancer using Irreversible Electroporation (IRE NanoKnife). Unlike heat-based ablation, IRE uses non-thermal electrical fields that safely destroy tumor cells right up to the vessel walls without damaging vital blood supply.

Pancreatic surgical centers in China routinely perform high-difficulty Whipple procedures and total pancreatectomies with vascular resection and reconstruction. All treatment plans are reviewed by a dedicated pancreatic MDT with transparent hospital fee schedules.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.
NanoKnife sends electrical pulses that puncture cancer cell membranes without generating heat. This protects the delicate celiac axis and superior mesenteric artery from burn damage.
Yes. With intensive modern conversion regimens combining chemotherapy, targeted therapies, and local ablation, a significant proportion of borderline and locally advanced tumors shrink enough for surgery.
In high-volume Chinese centers, specialized post-operative care and robotic approaches enable patients to walk within 48 hours and achieve discharge within 10 to 14 days.
Your contrast-enhanced thin-slice pancreatic CT/MRI scans are analyzed by senior pancreatic surgeons and interventional radiologists to assess vessel involvement and eligibility.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage  •  ✓ Direct specialist coordination  •  ✓ 100% Confidential

    Pancreatic Cancer

    There is Only One Thing In The World I Want
    And That Is Hospital.

    Copyright © 2026 PBM Infotech